These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29860331)

  • 1. Substandard and falsified medical products are a global public health threat. A pilot survey of awareness among physicians in Sweden.
    Funestrand H; Liu R; Lundin S; Troein M
    J Public Health (Oxf); 2019 Mar; 41(1):e95-e102. PubMed ID: 29860331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-Care Anti-Counterfeit Medicines Technologies: Awareness and Utilization among Medical Practitioners in Eastern Nigeria.
    Iloh GU; Akodu BA; Emeka EA; Obi IV
    West Afr J Med; 2021 Nov; Vol. 38(11):1029-1035. PubMed ID: 34918894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Where and how do you buy medicines?' A pilot survey of consumption strategies among the public in Sweden.
    Lundin S; Liu R
    J Public Health (Oxf); 2020 Aug; 42(3):e268-e271. PubMed ID: 31334767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    Ozawa S; Evans DR; Bessias S; Haynie DG; Yemeke TT; Laing SK; Herrington JE
    JAMA Netw Open; 2018 Aug; 1(4):e181662. PubMed ID: 30646106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance.
    Pisani E; Hasnida A; Rahmi M; Kok MO; Harsono S; Anggriani Y
    JMIR Public Health Surveill; 2021 Aug; 7(8):e29309. PubMed ID: 34181563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of community pharmacists' readiness to implement the Falsified Medicines Directive (Directive 2011/62/EC): an English cross-sectional survey with geospatial analysis.
    Barrett R
    BMJ Open; 2020 Jan; 10(1):e033405. PubMed ID: 31924640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V; Soloviov A; Olefir A
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives.
    Ahmed J; Modica de Mohac L; Mackey TK; Raimi-Abraham BT
    J Med Access; 2022; 6():23992026221074548. PubMed ID: 36204527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
    Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
    BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on the Development of Methods for Detection of Substandard and Falsified Medicines by Clarifying Their Pharmaceutical Characteristics Using Modern Technology.
    Yoshida N
    Biol Pharm Bull; 2024; 47(5):878-885. PubMed ID: 38692863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines.
    Anđelković M; Björnsson E; De Bono V; Dikić N; Devue K; Ferlin D; Hanževački M; Jónsdóttir F; Shakaryan M; Walser S
    BMC Health Serv Res; 2017 Jun; 17(1):419. PubMed ID: 28633634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring pharmacists' perspectives about substandard and falsified medical products through interviews.
    Persson A; Troein M; Lundin S; Midlöv P; Lenander C
    Explor Res Clin Soc Pharm; 2024 Mar; 13():100421. PubMed ID: 38405083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substandard and falsified medicines in African pharmaceutical markets: A case study from Ethiopia.
    Mengesha A; Bastiaens H; Ravinetto R; Gibson L; Dingwall R
    Soc Sci Med; 2024 May; 349():116882. PubMed ID: 38669893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications.
    El-Dahiyat F; Fahelelbom KMS; Jairoun AA; Al-Hemyari SS
    Front Public Health; 2021; 9():754279. PubMed ID: 34765583
    [No Abstract]   [Full Text] [Related]  

  • 18. Substandard and falsified medical products: bibliometric analysis and mapping of scientific research.
    Sweileh WM
    Global Health; 2021 Sep; 17(1):114. PubMed ID: 34556126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority.
    Mori AT; Meena E; Kaale EA
    BMJ Open; 2018 Jun; 8(6):e021825. PubMed ID: 29950474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries.
    Hauk C; Hagen N; Heide L
    Am J Trop Med Hyg; 2021 Mar; 104(5):1936-1945. PubMed ID: 33788775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.